Are you above the legal age to view this content in your province/state?

Home / Industry News / Cannabis Misinformation and COVID-19

Cannabis Misinformation and COVID-19

Cannabis Misinformation and COVID-19

U.S., May 6, 2020 (420 Intel)- While cow urine, bleach, and cocaine have all been recommended as bogus COVID-19 cures, the internet would be remiss to neglect its notoriously favorite panacea for all ailments: cannabis. Indeed, you do not need to venture far into the corners of mainstream media to find reports of proponents touting cannabis as a cure for COVID-19.

Unfortunately, the ugly marriage between cannabis and misinformation is terribly unsurprising. The recent explosion of health-related misinformation is so intense and far-reaching that the World Health Organization has dubbed it an “infodemic.”

And even prior to COVID-19 reaching pandemic proportions, cannabis-related hype had been making its rounds in recent years as a treatment for everything from cancer, to opioid addiction, to skincare.

In part, by virtue of its complexity, cannabis has earned the reputation in the eyes of some as a kind of magical elixir-like substance akin to the alchemical philosopher’s stone. It boasts over 500 chemical constituents and over 100 identified chemicals called cannabinoids that interact with our endocannabinoid system—a naturally occurring communication network throughout our brain and body that can affect many physiological and psychological processes, including gastrointestinal function, appetite, pain, memory, movement, immunity, inflammation, and mental health.

Given its remarkable complexity, it is no wonder that cannabis acts as a lightning rod for misinformation.

What do we know about cannabis and COVID-19?

A recent commentary by Dr. Kevin P. Hill in the journal, Cannabis and Cannabinoid Research, sums up nicely the current state of the scientific literature with respect to the therapeutic potential of cannabinoids for the treatment of viral illnesses.

First, it is important to note that to date, there are no studies that directly assess the effects of cannabinoids as a treatment for viral illnesses, including the large family of viruses that represent coronaviruses.

Additionally, while we know that some cannabinoids can exert anti-inflammatory effects, it remains unclear as to whether the anti-inflammatory activity of cannabinoids would be an advantage or a disadvantage when considering cannabinoids as a treatment for viruses.

Dr. Hill further explains the lack of clarity as: on the one hand, cannabinoids may be beneficial in viral infections where there is a need to decrease hyper-inflammation; and on the other hand, anti-inflammatory activity may be harmful when combating viruses because it could interfere with our own immune responses to acute viral infections, potentially leading to disease progression and even death.

Dr. Hill’s commentary also points to three non-human studies that have examined a role for cannabidiol (CBD)—one of the most famous cannabinoids found in the cannabis plant—as an antiviral agent. While the results of these studies suggest that CBD is a reasonable candidate to be further studied, Dr. Hill stresses that “we are very far from the level of evidence required to consider using cannabinoids as pharmacotherapy for viral illnesses.”

As such, as of right now, there is very limited, low-quality evidence that cannabis can be considered a viable treatment for COVID-19. With the pervasiveness of COVID-19-related fake science news and pseudoscience, it can be hard to know what to believe.

Don’t buy into the hype. When it comes to health, scientific evidence matters and is required to inform ethical, evidence-based health care.


Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.

Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.

Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.

Investment Value Finders is intended for those 21+ years of age only!

Check Also

Stocks and Founds that are overexposed To Russia And Ukraine

Stock markets worldwide have been in red since Russia began its invasion of Ukraine last …